This site is intended for health professionals only

14% of healthcare professionals feel sufficiently equipped to address prostate cancer patients’ QoL issues

A new report released entitled Prostate Cancer: Living, not Just Surviving, which details the findings from a large pan-European survey of 765 prostate cancer patients, 335 caregivers and 400 healthcare professionals, reveals that only 14% of healthcare professionals feel that they have sufficient resources to address quality of life issues, such as fatigue, pain and intimacy problems. (1)
 

A new report released entitled Prostate Cancer: Living, not Just Surviving, which details the findings from a large pan-European survey of 765 prostate cancer patients, 335 caregivers and 400 healthcare professionals, reveals that only 14% of healthcare professionals feel that they have sufficient resources to address quality of life issues, such as fatigue, pain and intimacy problems. (1)
 

Developed by Janssen in collaboration with pan-European and national patient associations, the survey reveals that for the patients who experience chronic physical effects from the disease, fatigue (66%) has the biggest negative impact compared to disability and pain (41% and 22% respectively), particularly in metastatic patients (93%) and patients on medication such as hormone treatment, chemotherapy and steroids (83%). Almost half of all men with prostate cancer surveyed (n=765) state that they are so tired, they no longer feel able to exercise and 74% of this group say that this has had a negative effect on them emotionally. (1)
 

It also suggests that men with prostate cancer worry more about quality of life issues associated with their disease, such as intimacy problems (54%) and feeling ill (41%), than dying (36%). (1)
 

The Prostate Cancer: Living, not Just Surviving report can be viewed online at: http://www.janssen-emea.com/hpc/reports/Living-prostate-cancer.

 

Reference:

  1. ‘Prostate Cancer: Living not just surviving’ report. Available at: http://www.janssen-emea.com/hpc/reports/Living-prostate-cancer





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x